# Robocath

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/robocath

- Industry: Medical Devices & Equipment
- Headquarters: Roubaix, France
- Website: www.robocath.com
- Total disclosed funding: $12M
- Latest round: Series C (May 19, 2020)
- Investors on record: 10

## About

Robocath SAS specializes in advanced robotic solutions for interventional vascular medicine, enhancing the precision and efficiency of coronary procedures with its flagship product, R-One™.Robocath SAS, founded in 2009 and headquartered in Roubaix, France, focuses on the development of robotic systems for percutaneous coronary interventions. Philippe Bencteux is the founder, who has a history in deep tech entrepreneurship. The company raised EUR 17 million in VENTURE DEBT financing in January 2022, which represents the total amount raised to date, totaling USD 9.00 mn over 9 deals.Robocath specializes in designing, developing, and commercializing robotic solutions aimed at improving interventional vascular medicine. Its flagship product, R-One™, assists in percutaneous coronary interventions (PCI) with bionic technology to enhance procedure precision. The system features an intuitive control unit and compatibility with leading market devices, targeting healthcare professionals like interventional cardiologists across Europe, Africa, and China.In 2022, Robocath generated revenue of USD 766,131.80, while reporting an EBITDA of USD -7,906,115.70, reflecting the company's investment in its growth and product development.Looking forward, Robocath plans to leverage its recent VENTURE DEBT financing raised in January 2022 to support the launch of new products designed to enhance existing robotic solutions. The company is also targeting expansion into new markets, with specific focus on increasing its presence in Asia and North America by 2025. These strategic initiatives aim to broaden the adoption of its technologies in the global healthcare landscape.

## Funding rounds

- Series C, May 19, 2020, $9.8M — Go Capital, Eurazeo PME, Microport Scientific Corporation, Anaxago, Tus-Holdings, Cardio Participation, WaterStart Capital, ZUIG Investment, CS Group
- Series B, May 11, 2018, $2M — Supernova Invest, Cardio Participation

## Investors

- Supernova Invest (https://capitalatlas.ai/funds/supernova-invest) — Series B
- Cardio Participation — Series B, Series C
- Go Capital — Series C
- Eurazeo PME — Series C
- Microport Scientific Corporation — Series C
- Anaxago — Series C
- Tus-Holdings — Series C
- WaterStart Capital — Series C
- ZUIG Investment (https://capitalatlas.ai/funds/zuig-investment) — Series C
- CS Group — Series C